Mri of spio-labeled mesenchymal stem cells in an animal model of acute renal failure at a clinical 3T system

Abstract

Optimized methods in MRI allow for qualitative and quantitative in-vivo cell-tracking and monitoring of organ distribution of SPIO-labeled MSC in clinical acute renal failure (ARF) in rate at a clinical 3T MR system. The study demonstrates the potential of in-vivo MRI for qualitative tracking and quantification of SPIO-labeled stem cells in future therapeutic treatment protocols.